Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain

Journal of Molecular Biology

Volumn 311, Issue 5, 2001, Pages 1011-1026

  Moriki, Takanori ^a   Maruyama, Hiroko ^a   Maruyama, Ichi N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cell surface receptor; Cysteine disulphide cross linking; Model; Molecular mechanism; Transmembrane signalling

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL SURFACE RECEPTOR; CYSTEINE; DIMER; DISULFIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; LIPID;

ANIMAL CELL; ARTICLE; CROSS LINKING; DIMERIZATION; DISULFIDE BOND; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MEMBRANE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; ROTATION; SUCROSE DENSITY GRADIENT CENTRIFUGATION;

EID: 0035979763     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4923     Document Type: Article

References (90)

1. Multiple positive and negative regulators of signaling by the EGF-receptor
2. EGF receptor in neoplasia and metastasis
3. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
4. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles
5. Receptor protein-tyrosine kinases and their signal transduction pathways
6. Protein modules and signalling networks
7. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
8. Requirement for c-ras proteins during viral oncogene transformation
9. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
10. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells
11. Regulation of inositol phospholipid-specific phospholipase C isozymes
12. The synthesis and cellular roles of phosphatidylinositol 4,5-bisphosphate
13. Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors
14. Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase
15. Association of epidermal growth factor receptors with coated pit adaptins via a tyrosine phosphorylation-regulated mechanism
16. Structural determinants of interaction of tyrosine-based sorting signals with the adaptor medium chains
17. Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes
18. Requirement for the adapter protein GRB2 in EGF receptor endocytosis
19. Signal-dependent membrane protein trafficking in the endocytic pathway
20. Endocytosis and molecular sorting
21. The EGF receptor: A nexus for trafficking and signaling
22. Cell signaling by receptor tyrosine kinases
23. Dimerization of cell surface receptors in signal transduction
24. Binding in the growth hormone receptor complex
25. Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation
26. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: A mechanism of interreceptor kinase activation and transphosphorylation
27. Implications of epidermal growth factor (EGF) induced egf receptor aggregation
28. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation
29. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: A fluorescence resonance energy transfer study
30. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
31. neu*
32. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface
33. Efficiency of signalling through cytokine receptors depends critically on receptor orientation
34. Receptor signaling: When dimerization is not enough
35. Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms
36. Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer
37. Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines
38. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
39. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)
40. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
41. A structural explanation for the recognition of tyrosine-based endocytotic signals
42. ATP is required for receptor-mediated endocytosis in intact cells
43. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors
44. Two EGF molecules contribute additively to stabilization of the EGFR dimer
45. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
46. Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor
47. Novel mechanisms of RTK signal generation
48. Signal transmission by epidermal growth factor receptor: Coincidence of activation and dimerization
49. SHC and GRB-2 are constitutively activated by an epidermal growth factor receptor with a point mutation in the transmembrane domain
50. Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism
51. Intrapeptide autophosphorylation of the epidermal growth factor receptor: Regulation of kinase catalytic function by receptor dimerization
52. Epidermal growth factor receptor dimerization monitored in live cells
53. The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation
54. Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions
55. Transformation and altered signal transduction by a naturally occurring mutant EGF receptor
56. Single-molecule imaging of EGFR signalling on the surface of living cells
57. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
58. Three-dimensional structures of the periplasmic lysine/arginine/ornithine-binding protein with and without a ligand
59. A model for transmembrane signalling by the aspartate receptor based on random-cassette mutagenesis and site-directed disulfide cross-linking
60. Atomic scale movement of the voltage-sensing region in a potassium channel measured via spectroscopy
61. Spectroscopic mapping of voltage sensor movement in the Shaker potassium channel
62. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
63. Regulation of kinase and intermolecular bonding in intact and truncated epidermal growth factor receptor
64. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents
65. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding
66. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond
67. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane
68. neu protein and EGF receptor modulates EGF receptor function
69. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: A mechanism for receptor transregulation
70. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
71. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185
72. Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase
73. Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro
74. Structural analysis of the transmembrane domain of the epidermal growth factor receptor
75. Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions
76. Neu receptor dimerization
77. Regulation of signal transduction and signal diversity by receptor oligomerization
78. Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors
79. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae
80. Transmembrane signaling by a chimera of the Escherichia coli aspartate receptor and the human insulin receptor
81. Four-helical-bundle structure of the cytoplasmic domain of a serine chemotaxis receptor
82. Apo structure of the ligand-binding domain of aspartate receptor from Escherichia coli and its comparison with ligand-bound or pseudoligand-bound structures
83. Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand
84. Imitation of Escherichia coli aspartate receptor signaling in engineered dimers of the cytoplasmic domain
85. Role of α-helical coiled-coil interactions in receptor dimerization, signaling, and adaptation during bacterial chemotaxis
86. A piston model for transmembrane signaling of the aspartate receptor
87. The two-component signaling pathway of bacterial chemotaxis: A molecular view of signal transduction by receptors, kinases, and adaptation enzymes
88. Affinity selection of cDNA libraries by λ phage surface display
89. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene
90. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase